分子名 |
货号 |
物种 |
表达系统 |
产品描述 |
纯度 |
特性 |
包装/价格 |
Cetuximab
|
CEB-Y31
|
Mouse
|
Hybridoma
|
Anti-Cetuximab Antibody (AY31) (Non-Neutralizing)
|
|
|
|
Rituximab
|
RIB-Y36
|
Mouse
|
Hybridoma
|
Anti-Rituximab Antibody (AY36) (recommended for ADA assay)
|
|
|
|
Adalimumab
|
ADB-Y19
|
Mouse
|
Hybridoma
|
Anti-Adalimumab Antibody (AY19)
|
|
|
|
Bevacizumab
|
BEB-Y12
|
Mouse
|
Hybridoma
|
Anti-Bevacizumab Antibody (AY12) (recommended for neutralizing assay)
|
|
|
|
FMC63
|
FM3-HPY53
DMF
|
Mouse
|
HEK293
|
PE-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Site-specific conjugation) (Preservative free)
|
|
|
|
MMAE
|
MME-M5252
|
Mouse
|
HEK293
|
Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (MALS verified)
|
|
|
|
IgG control
|
DNP-PM1
|
Mouse
|
HEK293
|
PE-Labeled Monoclonal Mouse IgG1 Antibody Isotype Control (Site-specific conjugation)
|
|
|
|
Cetuximab
|
CEB-BY31
|
Mouse
|
Hybridoma
|
Biotinylated Anti-Cetuximab Antibody (AY31) (recommended for PK/PD)
|
|
|
|
Bevacizumab
|
BEB-BY13
|
Mouse
|
Hybridoma
|
Biotinylated Anti-Bevacizumab Antibody (AY13) (recommended for PK/PD)
|
|
|
|
FMC63
|
FM3-FY45
DMF
|
Mouse
|
Hybridoma
|
FITC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45)
|
|
|
|
IgG control
|
DNP-M1A1
|
Mouse
|
HEK293
|
Mouse IgG1 kappa Antibody Isotype Control
|
|
|
|
CD28
|
GMP-MC2824
DMF
|
Mouse
|
HEK293
|
GMP Monoclonal Anti-Human CD28 Antibody
|
|
|
|
Cetuximab
|
CEB-Y27
|
Mouse
|
Hybridoma
|
Anti-Cetuximab Antibody (AY27) (recommended for ADA assay)
|
|
|
|
Bevacizumab
|
BEB-Y9
|
Mouse
|
Hybridoma
|
Anti-Bevacizumab Antibody (AY9) (recommended for ADA assay)
|
|
|
|
CD3
|
GMP-MC0323
DMF
|
Mouse
|
HEK293
|
GMP Monoclonal Anti-Human CD3 Antibody (OKT3)
|
|
|
|
IgG control
|
DNP-BM2
|
Human
|
HEK293
|
Biotinylated Human IgG1 Kappa Isotype Control (Biotin, mAb, carrier free, MALS verified)
|
|
|
|
FMC63
|
FM3-AY54P1
|
Mouse
|
HEK293
|
APC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Site-specific conjugation)
|
|
|
|
IFN-gamma
|
IFN-S120
|
Mouse
|
Hybridoma
|
Monoclonal Anti-IFNγ Antibody, Mouse IgG2a (8C5F8)
|
|
|
|
CD28
|
CD8-BM225
Avitag
|
Mouse
|
HEK293
|
Biotinylated Anti-Human CD28 Antibody, Mouse IgG1,Avitag™, premium grade
|
|
|
|
Cetuximab
|
CEB-Y28
|
Mouse
|
Hybridoma
|
Anti-Cetuximab Antibody (AY28)
|
|
|
|
Rituximab
|
RIB-Y37
|
Mouse
|
Hybridoma
|
Anti-Rituximab Antibody (AY37) (recommended for PK/PD)
|
|
|
|
Rituximab
|
RIB-Y35c
|
Mouse
|
HEK293
|
Anti-Rituximab Antibody (MALS verified)
|
|
|
|
Rituximab
|
RIB-FY35c
|
Mouse
|
Hybridoma
|
FITC-Labeled Anti-Rituximab Antibody, Mouse IgG1
|
|
|
|
Adalimumab
|
ADB-Y23b
|
Mouse
|
HEK293
|
Anti-Adalimumab Antibody (AY23b) (recommended for PK/PD)
|
|
|
|
Bevacizumab
|
BEB-Y10
|
Mouse
|
Hybridoma
|
Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
|
|
|
|
Trastuzumab
|
TRB-Y5b
|
Mouse
|
HEK293
|
Anti-Trastuzumab Antibody (AY5b) (recommended for PK/PD)
|
|
|
|
Trastuzumab
|
TRB-Y1b
|
Mouse
|
HEK293
|
Anti-Trastuzumab Antibody (AY1b) (recommended for PK/PD)
|
|
|
|
FMC63
|
FM3-AY54A1
|
Mouse
|
HEK293
|
APC-Labeled Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (Site-specific conjugation) (0.03% Proclin)
|
|
|
|
FMC63
|
FM3-Y45P1
DMF
|
Mouse
|
HEK293
|
Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (HEK293)
|
|
|
|
FMC63
|
FM3-Y45
DMF
|
Mouse
|
Hybridoma
|
Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45)
|
|
|
|